- Home
- SYRE vs KSS Comparison
SYRE vs KSS Comparison
Compare SYRE & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | KSS |
|---|---|---|
| Founded | 2013 | 1962 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | 2015 | 1995 |
Fundamental Metrics
Financial Performance| Metric | SYRE | KSS |
|---|---|---|
| Price | $41.49 | $13.79 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 7 | 14 |
| Target Price | ★ $55.57 | $16.17 |
| AVG Volume (30 Days) | 680.5K | ★ 4.1M |
| Earning Date | 05-19-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.43% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.30 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.17 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.91 | $6.04 |
| 52 Week High | $45.76 | $25.22 |
Technical Indicators
Market Signals| Indicator | SYRE | KSS |
|---|---|---|
| Relative Strength Index (RSI) | 61.24 | 25.10 |
| Support Level | $15.01 | $12.16 |
| Resistance Level | $45.76 | $17.04 |
| Average True Range (ATR) | 2.33 | 0.99 |
| MACD | -0.28 | -0.30 |
| Stochastic Oscillator | 47.86 | 1.94 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About KSS Kohl's Corporation
Kohl's operates about 1,150 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also has a large digital sales operation. Women's apparel is Kohl's largest category, having generated 25% of its 2024 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.